🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

115 results for “SINOVAC” Clear

  1. Concomitant administration of EV71 vaccine with EPI vaccines

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  2. Concomitant administration of EV71vaccine with EPI vaccines

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  3. EV71 Vaccine

    SINOVAC BIOTECH LTD

    EV71 Vaccine

    approved mab completed

    1 trial

  4. EV71 inactived vaccine（Vero cells）

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  5. EV71 vaccine

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  6. Experimental 23-valent PPV

    SINOVAC BIOTECH LTD

    Pneumococcal Infections

    approved mab completed

    1 trial

  7. Experimental 23-valent Pneumococcal

    SINOVAC BIOTECH LTD

    Pneumococcal Infections

    approved mab completed

    1 trial

  8. Experimental Group

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab completed

    4 trials

  9. Experimental Vaccine

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial

  10. Experimental vaccine 1

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab on hold

    1 trial

  11. H1N1 influenza A Vaccine (PANFLU.1)

    SINOVAC BIOTECH LTD

    Influenza

    approved mab completed

    1 trial

  12. H1N1 influenza A Vaccine (Split virion), Inactivated

    SINOVAC BIOTECH LTD

    Influenza

    approved mab completed

    1 trial

  13. Healive (hepatitis A vacine(human diploid cell), inactivated)

    SINOVAC BIOTECH LTD

    Hepatitis A

    approved mab active

    1 trial

  14. Healive+Healive

    SINOVAC BIOTECH LTD

    Hepatitis A

    approved mab completed

    1 trial

  15. Healive® Lot 1

    SINOVAC BIOTECH LTD

    Hepatitis A

    approved mab completed

    1 trial

  16. High-dosage SARS-CoV-2 vaccine

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab active

    1 trial

  17. High-dosage of COVID-19 vaccine (Vero cell), Inactivated

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab completed

    1 trial

  18. Inactivated COVID-19 Vaccine

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab active

    4 trials

  19. Inactivated HAV vaccine

    SINOVAC BIOTECH LTD

    Hepatitis A

    approved mab completed

    1 trial

  20. Inactivated Hepatitis A vaccine (HAV)

    SINOVAC BIOTECH LTD

    Hepatitis A

    approved mab completed

    1 trial

  21. Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab active

    1 trial

  22. Inactivated SARS-CoV-2 Vaccine (Vero cell）

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab completed

    1 trial

  23. Investigational 23-valent PPV

    SINOVAC BIOTECH LTD

    Pneumococcal Infections

    approved mab completed

    2 trials

  24. Investigational live attenuated varicella vaccine

    SINOVAC BIOTECH LTD

    Varicella

    approved mab active

    4 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources